SUZHOU, China, May 7, 2025 /PRNewswire/ -- CStone Pharmaceuticals ('CStone', HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster ...

Applying limited proteolysis using endoproteinase Lys-C resulted in the predominant cleavage C-terminal of this lysine residue. ... two identical Fab domain fragments and one Fc domain fragment ...

SAN MATEO, Calif.--(BUSINESS WIRE)--EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader ...

Their paper, "A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response," was recently accepted and published in the Science Translational Medicine journal.

The Kaiser Permanente Hawaii Viral Hepatitis Clinic reached a milestone by curing its 1,000th patient of hepatitis C. “It’s a very satisfying thing to make that call and tell someone they’re ...

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle disease trial ahead of a planned push to regulators.. Abcuro is ...

SportsWatch This 23-year-old tennis player won almost $264,000 at the Australian Open after not originally qualifying. Here’s how. Eva Lys had already booked a flight home after initially ...

Background: MCLA-129 is a common light chain, Biclonics, bispecific antibody targeting EGFR and c-MET with enhanced antibody-dependent cellular cytotoxicity. Here we describe the ongoing ...

Zenas BioPharma has bagged a $200 million series C, extending its cash runway another 18 months through a raft of key readouts for its lead monoclonal antibody obexelimab. The new financing ...

OncoResponse lands $27M to advance development of antibody-based treatments for cancer. by Nate Bek on May 18, 2023 at 5:00 am May 17, 2023 at 11:57 pm.